Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Alfresa Holdings ( (JP:2784) ) has issued an update.
Alfresa Holdings reported a year-on-year increase in its financial performance for the nine months ending December 31, 2024, with net sales reaching ¥2,262,324 million, marking a 3.8% increase. Despite this growth, the company anticipates a slight decrease in operating profit for the fiscal year ending March 31, 2025, due to adjustments in accounting policies and market conditions, which may affect stakeholder expectations.
More about Alfresa Holdings
Alfresa Holdings Corporation operates in the healthcare and pharmaceutical industry, primarily focusing on the distribution of pharmaceutical products, medical devices, and health-related materials across Japan. The company is listed on the Prime Market of the Tokyo Stock Exchange, indicating its significant role in the Japanese market.
YTD Price Performance: -1.12%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.64B
For an in-depth examination of 2784 stock, go to TipRanks’ Stock Analysis page.
